$9.50
0.454.97%
At close: Sep 4, 5:00 PM EST
$9.41
-0.09-0.95%
After Hours: Sep 4, 7:31 PM EST
Phathom Pharmaceuticals Inc
PHATNASDAQ
Phathom Pharmaceuticals Earnings & Forecasts
Phathom Pharmaceuticals (PHAT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Phathom Pharmaceuticals Guidance
Phathom Pharmaceuticals (PHAT) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided revenue in the range of $310M - $325M for the period.
Compared to prior guidance, Phathom Pharmaceuticals lowered its revenue forecast from a prior range of $320M - $345M.
Phathom Pharmaceuticals has issued 7 guidance updates between August 6, 2025 and July 30, 2026. During this period, the company raised its outlook 3 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.21 | $-0.19 | $-0.41 |
| Actual | $0.00 | $-0.18 | $-0.08 | $-0.15 |
| Surprise | +100.0% | +14.3% | +57.9% | +63.4% |
| Revenue | ||||
| Estimate | $73.6M | $56.8M | $57.4M | $47.9M |
| Actual | $74.3M | $58.3M | $57.6M | $49.5M |
| Surprise | +1.01% | +2.66% | +0.26% | +3.41% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.03 | $0.10 |
| Revenue | ||
| Consensus | $85.7M | $98.7M |
